These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

955 related items for PubMed ID: 19695384

  • 1. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
    Comi G.
    Clin Ther; 2009 Jun; 31(6):1142-57. PubMed ID: 19695384
    [Abstract] [Full Text] [Related]

  • 2. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Thrower BW.
    Neurology; 2007 Jun 12; 68(24 Suppl 4):S12-5. PubMed ID: 17562845
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D.
    Neurology; 2011 Jan 04; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
    Pakdaman H, Sahraian MA, Fallah A, Pakdaman R, Ghareghozli K, Ghafarpour M, Rahimian E, Shirani A.
    Acta Neurol Scand; 2007 Jun 04; 115(6):429-31. PubMed ID: 17511854
    [Abstract] [Full Text] [Related]

  • 7. High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study.
    Barbero P, Verdun E, Bergui M, Pipieri A, Clerico M, Cucci A, Ricci A, Bergamasco B, Durelli L.
    J Neurol Sci; 2004 Jul 15; 222(1-2):13-9. PubMed ID: 15240190
    [Abstract] [Full Text] [Related]

  • 8. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
    Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW.
    N Engl J Med; 2000 Sep 28; 343(13):898-904. PubMed ID: 11006365
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria.
    O'Connor P, Kinkel RP, Kremenchutzky M.
    Mult Scler; 2009 Jun 28; 15(6):728-34. PubMed ID: 19482863
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The importance of early diagnosis of multiple sclerosis.
    Miller JR.
    J Manag Care Pharm; 2004 Jun 28; 10(3 Suppl B):S4-11. PubMed ID: 15253684
    [Abstract] [Full Text] [Related]

  • 12. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.
    Goodin DS, Bates D.
    Mult Scler; 2009 Oct 28; 15(10):1175-82. PubMed ID: 19737851
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
    Weinstock-Guttman B, Bhasi K, Badgett D, Tamaño-Blanco M, Minhas M, Feichter J, Patrick K, Munschauer F, Bakshi R, Ramanathan M.
    J Neuroimmunol; 2008 Dec 15; 205(1-2):113-25. PubMed ID: 18950872
    [Abstract] [Full Text] [Related]

  • 15. Interferon beta and multiple sclerosis: look at the evidence.
    Patti F, Reggio A.
    Int J Clin Pract Suppl; 2002 Sep 15; (131):23-32. PubMed ID: 12564809
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Advancing treatment with interferon beta-1b (Betaferon/Betaseron) in the next decade--thinking beyond the standard dose.
    Cook SD.
    J Neurol; 2003 Dec 15; 250 Suppl 4():IV15-20. PubMed ID: 14712397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.